Cortina Asset Management’s Emergent Biosolutions EBS Stock Holding History

Cortina Asset Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$13.6M	Buy	282,255 +12,494	+5%	+$599K	0.84%	32
2019 Q1	$13.6M	Buy	269,761 +183,723	+214%	+$10.8M	0.85%	36
2018 Q4	$5.1M	Buy	+86,038	New	+$5.55M	0.31%	124

Other funds holding EBS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

Cortina Asset Management's EBS Position: Q2 2019 in Review

Cortina Asset Management increased its Emergent Biosolutions (EBS) stake by 4.6% in Q2 2019, buying an estimated $599K and bringing the position to 282,255 shares worth $13.6M. The position accounts for 0.84% of the portfolio, ranked #32.

Cortina Asset Management first reported a position in EBS in Q4 2018 and has held it in 3 quarters since. 233 funds tracked by Wall St. Rank hold EBS as of Q2 2019.

Cortina Asset Management held 282,255 shares of Emergent Biosolutions worth $13.6M as of Q2 2019.
Cortina Asset Management bought 12,494 Emergent Biosolutions shares in Q2 2019, an estimated $599K.
Emergent Biosolutions made up 0.84% of Cortina Asset Management's portfolio in Q2 2019, its #32 holding.
Cortina Asset Management first reported a position in Emergent Biosolutions in Q4 2018 and has held it in 3 quarters since.
233 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2019.

Based on Cortina Asset Management's 13F filing for Q2 2019, filed 2 Jul 2019.